Oncology & Cancer

Errant DNA boosts immunotherapy effectiveness

DNA that ends up where it doesn't belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate. The findings, published online ...

Diseases, Conditions, Syndromes

RAS inhibitors not linked to increased risk of death from COVID-19

Concerns have been raised that the use of a common group of medications called RAS inhibitors could facilitate SARS-CoV-2 infection, impact COVID-19 disease severity and worsen prognosis. However, in a new nationwide registry-based ...

Immunology

Boosting stem cell activity can enhance immunotherapy benefits

Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active "super immune cells" with strong antitumor activity, according to new research from Georgetown ...

Medications

US approves Regeneron antibody treatment given to Trump

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.

Diseases, Conditions, Syndromes

Two studies focus on SARS-CoV-2 transmission in domestic cats, pigs

Two recently published studies from Kansas State University researchers and collaborators have led to two important findings related to the COVID-19 pandemic: Domestic cats can be asymptomatic carriers of SARS-CoV-2, but ...

page 38 from 40